Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Newton | Neurolens

Request full access

Designs prescription lenses that add a contoured prism to bring the eyes into alignment

Coppell, United StatesFounded 2012Health Tech & Medtech

About Newton | Neurolens

Newton (formerly Neurolens, originally EyeBrain Medical) is an eyecare-technology company founded in 2012 that develops therapeutic prescription lenses addressing vision misalignment — the underlying cause of symptoms such as headaches, neck pain, eye strain and motion sickness. Its flagship NeuroLens system pairs the N3 diagnostic device, which uses VR and eye tracking to measure binocular misalignment, with the first prescription lenses to feature patented Contoured Prism™ technology; the company reports that 90% of patients experience symptom relief. In September 2025 the company rebranded from Neurolens to Newton, and it has since expanded its portfolio with Sequel, an everyday lens built on Convergence Boost™ technology, and acquired Founders Optical Lab in late 2025. Newton has raised over $170 million to date — including a $67 million round in 2022 led by MVM Life Science Partners with KKR, Marshall Wace and Bluestem Capital, and a $45 million growth investment from Trinity Capital in 2023 — and distributes through independent eye care providers across North America. Led by CEO Davis Corley, the company is headquartered in Coppell, Texas.

Source: Dealroom company data

At a glance

Status
Operational
Employees
139
Open positions
None listed
Dealroom signal
68.6/100
Industry
Health
Sub-industry
Health Platform
Sector
Neurology, Optical Technology, Hard Tech
Business model
Manufacturing, Marketplace & ecommerce
Client focus
B2B, B2C
Investment activity
1 company, latest Nov 2025
Capital deployed
—
Preferred round
ACQUISITION

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Dec 2023 $45M — Trinity Capital ↗
LATE VCOther financing Sep 2022 $67M $268M Bluestem Capital · MVM Life Science Partners · KKR · Marshall Wace ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Newton | Neurolens website traffic

Latest recorded traffic for Newton | Neurolens is 14K monthly website visits, down 6.7% over the last three months. Newton | Neurolens's team grew 0% over the past year.

Latest monthly visits14K 3-month web change-6.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Newton | Neurolens in the Coppell ecosystem

Live from Dealroom

The Newton | Neurolens office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • MVM Life Science Partners
  • Bluestem Capital
  • KKR
  • Marshall Wace
  • Trinity Capital
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Coppell HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Newton | Neurolens on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Newton | Neurolens’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.